APA (7th ed.) Citation

Szabo, S. M., Hirji, I., Johnston, K. M., Juarez-Garcia, A., & Connors, J. M. (2017). Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study. PLoS ONE, 12(10), 1. https://doi.org/10.1371/journal.pone.0180261

Chicago Style (17th ed.) Citation

Szabo, Shelagh M., Ishan Hirji, Karissa M. Johnston, Ariadna Juarez-Garcia, and Joseph M. Connors. "Treatment Patterns and Costs of Care for Patients with Relapsed and Refractory Hodgkin Lymphoma Treated with Brentuximab Vedotin in the United States: A Retrospective Cohort Study." PLoS ONE 12, no. 10 (2017): 1. https://doi.org/10.1371/journal.pone.0180261.

MLA (9th ed.) Citation

Szabo, Shelagh M., et al. "Treatment Patterns and Costs of Care for Patients with Relapsed and Refractory Hodgkin Lymphoma Treated with Brentuximab Vedotin in the United States: A Retrospective Cohort Study." PLoS ONE, vol. 12, no. 10, 2017, p. 1, https://doi.org/10.1371/journal.pone.0180261.